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Although current guidelines recommend performing endoscopy within 12 hours for acute variceal bleeding 
(AVB), the optimal timing remains controversial. This study aimed to assess the effect of endoscopy 
timing on the mortality and rebleeding rates in AVB through a systematic review and meta-analysis of all 
eligible studies. pubMed, cochrane Library, and embase were searched for relevant publications up to 
January 2019. Overall mortality, rebleeding rate, and other clinical outcomes were determined. For the 
non-randomized studies, the risk of bias assessment tool was used to assess the methodological quality of 
the included publications. The Mantel-Haenszel random-effects model of the RevMan software (Cochrane) 
and the inverse variance method were used to analyse binary end points and continuous outcomes, 
respectively. This meta-analysis included five studies with 854 and 453 participants who underwent 
urgent (≤12 hours) and non-urgent endoscopies (>12 hours), respectively. All the included studies 
were retrospective in nature, because of obvious ethical issues. No significant differences in the severity 
indexes were found between the urgent and non-urgent groups. Three studies showed 6-week mortality 
and the others in-hospital mortality as main outcomes. No significant difference in overall mortality rate 
was found between the groups (odds ratio [OR]: 0.72, 95% confidence interval [CI]: 0.36–1.45, p = 0.36). 
The rebleeding rate was similar between the two groups (OR: 1.21, 95% CI: 0.76–1.93, p = 0.41). Other 
outcomes such as successful haemostasis, need for salvage therapy, length of hospital stay, and number 
of blood transfusions were also similar between the groups. We demonstrated that endoscopy timing 
does not affect the mortality or rebleeding rate of patients with AVB. Therefore, an appropriate timing of 
endoscopy would be more important than an urgent endoscopy depending on each patient’s condition.
Acute variceal bleeding (AVB) is a common complication of cirrhosis. It is associated with a mortality rate of 
20–25%1,2. Endoscopic therapy (e.g., band ligation and sclerotherapy) has been used as the treatment of choice 
for controlling AVB, in accordance with most guidelines that recommend endoscopic therapy to be performed 
within 12 hours of admission3,4. However, these recommendations are based on “expert opinion” and require 
corroborating evidence.
To date, several studies have been conducted on the timing of endoscopy for patients with AVB. Some stud-
ies showed that endoscopy timing is not associated with mortality or rebleeding rate in patients with AVB5–7. 
However, in two studies published in Taiwan, non-urgent endoscopy appeared to be an independent risk factor of 
mortality in patients with AVB8,9. Such inconsistency between studies raised questions about the optimal timing 
of endoscopy for patients with AVB. Conducting a randomized controlled trial would be the best way to deter-
mine the optimal endoscopy timing but would be difficult because of obvious ethical concerns.
Although several studies have reported the optimal endoscopy timing in patients with AVB, whether urgent 
endoscopy decreases composite outcomes in patients with AVB remains unclear. Therefore, the objective of this 
study was to conduct a meta-analysis of trials to evaluate the effect of endoscopy timing on mortality and rebleed-
ing in patients with AVB.
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Materials and Methods
Literature search strategy. In this study, systematic review and meta-analysis were performed on the basis 
of the principles of the PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) state-
ment10. PubMed, Cochrane Library, and Embase (from inception to January 2019) were searched independently 
by two authors (CWH and DHJ). The following search string was used: esophageal and gastric varices [Mesh 
Terms] OR gastroesophageal varices [Text Word] OR esophageal varices [Text Word] OR gastric varices [Text 
Word] OR hemorrhage [Mesh Terms] OR gastrointestinal hemorrhage [Mesh Terms] OR variceal bleeding [Text 
Word] AND endoscopy [Mesh Terms] OR esophagoscopy [Mesh Terms] OR gastroscopy [Mesh Terms] OR 
hemostasis [Mesh Terms] OR endoscopic band ligation [Text Word] OR endoscopic sclerotherapy [Text Word], 
endoscopy timing [Text Word]. The detailed search strategies in each database are shown in Supplementary 
Table 1. Cited references in published studies were manually and repetitively searched to identify other studies. 
The latest date for updating our search was January 31, 2019.
Study selection. In the first stage of the study selection, the title and abstract of articles that our keyword 
search returned were scrutinized to rule out irrelevant articles. No language restriction was imposed in this stage. 
Next, in accordance with our inclusion and exclusion criteria, the full texts of all selected studies were screened. 
The inclusion criteria were as follows: (1) a diagnosis of AVB; (2) urgent endoscopic haemostasis (e.g., endoscopic 
band ligation and sclerotherapy) as an intervention; (3) non-urgent endoscopic haemostasis as a comparator; and 
(4) mortality or rebleeding as outcome. The exclusion criteria were as follows: (1) review article; (2) guidelines or 
consensus documents or expert position papers; (3) comments, letters, brief reports, and protocol studies; (4) case 
reports; (5) abstract-only publications; (6) publication in a language other than English; (7) meta-analysis articles; 
or (8) studies using sclerotherapy as initial treatment for oesophageal variceal bleeding.
Data extraction. Two review authors (CWH and DHJ) independently extracted data from the included 
studies using a pre-data extraction form. The titles and abstracts of all included studies were reviewed to exclude 
irrelevant publications. Discrepancies in data interpretation were resolved by discussion, re-review of studies, 
and consultation with one other author (BWK) when necessary. The following information was extracted: year 
of publication, first author, study design, age and sex of patients, sample size, inclusion and exclusion criteria of 
the trial, aetiology of liver disease, Child-Pugh score, Model for End-stage Liver Disease (MELD) score, endos-
copy timing, mortality rate, rebleeding rate, successful haemostasis, need for salvage therapy, length of hospi-
tal stay, and number of blood units transfused. Whereas endoscopy performed after >12 hours was considered 
non-urgent endoscopy, endoscopy performed in ≤12 hours was considered as urgent endoscopy. Mortality was 
defined as in-hospital or 6-week mortality. Rebleeding was defined as hematemesis, melena, or haematochezia 
with accompanying changes in laboratory findings or vital signs.
Methodological quality. The Risk of Bias Assessment tool for Non-randomized Studies (RoBANS) was 
used for the assessment of the methodological quality of the included publications11. RoBANS has six domains. It 
is a validated tool that is reliable and feasible for assessing the methodological quality of non-randomized studies. 
Two authors (CWH and DHJ) independently assessed the methodological quality of the included studies. Any 
disagreement between the two evaluators was resolved by discussion.
Statistical analysis. We used Review Manager version 5.3 (RevMan for Windows 7, the Nordic Cochrane 
Centre, Copenhagen, Denmark). The Mantel-Haenszel random-effect model was used for binary end points, and 
the inverse variance method was used for continuous outcomes. The random-effect model was chosen because 
it could take into account the possibility of heterogeneity between studies. The I2 test developed by Higgins was 
used for determining heterogeneity12. It measures the percentage of total variation across studies. I2 was calcu-
lated as follows: I2 (%) = 100 × (Q-df)/Q, where Q is Cochrane’s heterogeneity statistics and df was the degree 
of freedom. Heterogeneity was quantified on the basis of the following cut-off criteria: 0–25%, low; 25–50%, 
moderate; and >50%, high heterogeneity12. In cases of significant heterogeneity (I2 >25%), the methodological 
section of each study was reassessed for determining whether any discrepancy could be identified. Following this 
process, sensitivity analyses were performed to rule out the discrepant study. A p value of < 0.05 was considered 
statistically significant.
Results
Study selection. Figure 1 summarizes the flow diagram of the selection of studies for inclusion in the 
meta-analysis. A total of 12,104 studies were identified in our literature search. Duplicated articles (n = 2,084) 
were excluded. After initial screening of titles and abstracts, 10,005 studies were additionally excluded. The full 
texts of the remaining 15 studies were then thoroughly reviewed. Among these studies, 10 articles were excluded 
from the final analysis due to the following reasons: irrelevant study on endoscopy timing (n = 5), irrelevant study 
on current clinical practice (n = 3), and insufficient data (n = 2). The remaining five studies were included in the 
final quantitative analysis.
characteristics of the included studies. The baseline characteristics of the included studies are listed in 
Table 1. A total of 1,307 patients were included, with 854 and 453 patients in the urgent and non-urgent groups, 
respectively. All the articles were retrospective studies published within the last 10 years (2009–2019). They were 
from Taiwan (n = 2), Korea (n = 2), and Canada (n = 1).
All the studies except two (Chen study8 and Hsu study9) compared the baseline characteristics between the 
two arms. In all the studies except one9, endoscopies performed in ≤12 and >12 hours were considered urgent 
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and non-urgent endoscopies, respectively. In the study of Hsu et al.9, urgent endoscopy was defined as an endos-
copy performed within 15 hours; and non-urgent endoscopy, as endoscopy performed after 15 hours.
Except in the study by Hsu et al.9 no significant differences in the severity indexes (MELD score, Child-Pugh 
score, vital sign, prognostic score, and infection) were found between the urgent and non-urgent groups 
(Supplementary Table 2). In two studies5,7, the main outcomes, such as mortality and rebleeding rates, did not 
show significant differences between the two groups after propensity score matching. We added information 
related to the treatment outcome in Supplementary Table 3. All the studies included in this meta-analysis used 
vasoactive agents. Moreover, prophylactic antibiotics were used in all the studies except one9. We could not find 
information about prophylactic antibiotics in one study9. The proportion of patients with oesophageal varix 
bleeding was greater than that of the patients with gastric varix bleeding in the pooled analysis. All the studies 
included in the meta-analysis showed 6-week mortality5,7,8 or in-hospital mortality6,9 as main outcomes. The cause 
of death was reported in two studies6,8. We could check the definition of rebleeding in three studies. The definition 
of rebleeding in most of the studies was new-onset hematemesis, melena, or haematochezia with accompanying 
changes in laboratory findings (decrease in haemoglobin level by >2 g/dL within 24 hours) or vital signs (decrease 
in systolic blood pressure to <100 mmHg or increase in heart rate to >100 beats/min).
Methodological quality. All the included studies were observational retrospective studies. The methodo-
logical qualities of the included studies were similar. Two studies had a high risk of participant comparability and 
confounding variables8,9. It did not compare baseline characteristics between the two arms. Figure 2 details the 
quality of these included studies.
outcomes. Mortality. All the studies reported data on mortality for 1,307 patients as shown in Fig. 3. The 
pooled analysis revealed that the overall mortality rate was similar between the urgent and non-urgent groups 
(odds ratio [OR]: 0.72, 95% confidence interval [CI]: 0.36–1.45, p = 0.36). A high heterogeneity was observed 
between the studies (p = 0.006, I2 = 73%). A sensitivity analysis was performed after excluding studies that did 
not compare baseline characteristics between the two arms8,9. This analysis did not eliminate the heterogeneity 
between the studies (p = 0.09, I2 = 58%) (Supplementary Table 4).
Figure 1. Flow diagram of the studies included in the meta-analysis.











Cheung et al.6 2009 Retrospective urgent: 134non-urgent: 76 179/31 55 139 alcohol/59 viral/47 other 8.5 14.3
Hsu et al.9 2009 Retrospective urgent: 176non-urgent: 135 228/83 55 46 alcohol/228 viral/37 other NA 11.6
Chen et al.8 2012 Retrospective urgent: 54non-urgent: 47 85/16 57 18 alcohol/74 viral/9 other 9* 13*
Yoo et al.5 2018 Retrospective urgent: 173non-urgent: 101 207/67 58 69 alcohol/162 viral/43 other NA 15.9
Huh et al.7 2019 Retrospective urgent: 317non-urgent: 94 291/120 54 240 alcohol/136 viral/31 other 8.3 12.1
Table 1. Baseline characteristics of the five studies included. MELD, model for end-stage liver disease; NA, not 
available. *Data expressed as median values.
4Scientific RepoRtS |         (2020) 10:4046  | https://doi.org/10.1038/s41598-020-60866-x
www.nature.com/scientificreportswww.nature.com/scientificreports/
Rebleeding. Data on rebleeding were available for four studies that reported the information of 996 patients 
as shown in Fig. 4. The pooled analysis revealed that the rebleeding rate was similar between the urgent and 
non-urgent groups (OR: 1.21, 95% CI: 0.76–1.93, p = 0.41). A moderate heterogeneity was observed between the 
studies (p = 0.12, I2 = 49%). A sensitivity analysis was performed, excluding the study that did not compare base-
line characteristics between the two arms8. This analysis did not eliminate the heterogeneity between the studies 
(p = 0.07, I2 = 63%) (Supplementary Table 4).
Other clinical outcomes. Table 2 summarizes the other outcomes according to endoscopy timing in the included 
studies. Data on other outcomes (successful haemostasis, need for salvage therapy, length of hospital stay, and 
number of blood transfusions) were available in two studies that reported the information of 621 patients (Fig. 5, 
Table 2)6,7. The pooled analysis demonstrated that other outcomes were similar between the two groups (Fig. 5, 
Table 2).
Discussion
This systematic review and meta-analysis aimed to compare the effect of endoscopy timing on mortality and 
rebleeding in patients with AVB. We found no significant differences in overall mortality (OR: 0.72, 95% CI: 
0.36–1.45, p = 0.36) or rebleeding rate (OR: 1.21, 95% CI: 0.76–1.93, p = 0.41) according to endoscopy timing. 
Other clinical outcomes were also similar between the urgent and non-urgent groups.
Although most guidelines suggest performing endoscopy within 12 hours, the optimal endoscopy timing for 
AVB remains controversial3,4. Hsu et al. compared urgent endoscopy with non-urgent endoscopy and showed 
that non-urgent endoscopy is significantly associated with increased risk of mortality9. However, unlike the rec-
ommendations of the guidelines, they defined urgent endoscopy as that performed within 15 hours. They did not 
provide data regarding baseline characteristics between the urgent and non-urgent groups either. Similarly, Chen 
et al. revealed that urgent endoscopy is associated with better outcome in patients with hematemesis8. However, 
endoscopy timing was not associated with mortality or rebleeding in patients without hematemesis. They also did 
not show data regarding baseline characteristics between the urgent and non-urgent groups. By contrast, Cheung 
et al. showed no significant association between time to endoscopy and mortality or rebleeding in the patients 
with hemodynamically stable AVB6. However, they included only patients who presented with hemodynamically 
Figure 2. Risk of bias of the enrolled studies.
Figure 3. Forrest plot of the overall mortality rate for comparison between the urgent and non-urgent groups.
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stable variceal bleeding. More recently, in two studies published in Korea, endoscopy timing was not associated 
with morality or rebleeding in patients with AVB5,7. They included more patients than the previous studies and 
adjusted for various confounders by performing propensity score matching.
In the present meta-analysis, endoscopy timing did not influence mortality or rebleeding rate in the patients 
with AVB. One study showed that urgent endoscopy may even be harmful to some patients in terms of mortal-
ity and rebleeding7. The study divided patients into a low-risk group (MELD score ≤17) and a high-risk group 
(MELD score >17) according to the severity of the underlying liver disease. It concluded that urgent endoscopy 
was significantly associated with poorer outcome in low-risk patients, whereas endoscopy timing was not asso-
ciated with outcome in the high-risk patients. Some possible explanations for this result are as follows: First, 
the quality of endoscopic examination and therapy is likely to be suboptimal in urgent endoscopy owing to the 
remaining food and blood in the stomach. Second, urgent endoscopy may be related with suboptimal resuscita-
tion. It could be plausible that sufficient time for pre-endoscopic optimization of the patient’s clinical state would 
be more determinant than the endoscopy timing in some patients.
The results of this meta-analysis suggest that prognostic factors more crucial than endoscopy timing exist in 
patients with AVB. Several studies revealed that factors associated with worsened prognosis include the severity 
of liver disease (MELD or Child-Pugh score), shock at the time of hospital admission, infection, and hepato-
cellular carcinoma13–17. Among these factors, the severity of liver disease has been considered as a well-known 
prognostic factor. It is closely associated with clinical outcome such as mortality15,18. In patients with significant 
comorbid illness, stable hemodynamics, or preserved liver function, postponing endoscopic intervention until 
adequate medical therapy is administrated (e.g., intravenous vasopressin, antibiotics, and fluid resuscitation) 
could be beneficial and allow time to optimize the patients’ conditions6,7. Therefore, an “appropriate timing of 
endoscopy” would be more important than an “urgent endoscopy” depending on the patient’s condition.
Although this was the first systematic review and meta-analysis to compare the effect of endoscopy timing on 
mortality and rebleeding in patients with AVB, it had several limitations. First, all the included studies were retro-
spective in nature without randomization. This could have led to considerable selection bias in our study. As most 
guidelines recommend performing endoscopy within 12 hours, the number of patients in the urgent group was 
higher than that in the non-urgent group in this meta-analysis. In most studies, the criteria for urgent endoscopy 
included the endoscopist’s decision to perform urgent endoscopy in consideration of the patient’s condition and 
the feasibility of endoscopy. As these are subjective criteria according to the endoscopist’s decision, this might 
cause risk of bias. However, we could not find objective criteria for deciding between urgent and non-urgent 
endoscopies. In addition, the patients who underwent urgent endoscopy could be more ill than those who under-
went non-urgent endoscopy. This bias could have affected the results of our study. However, the severity index 
was not significantly different between the urgent and non-urgent groups in each study (Supplementary Table 2). 
In addition, the main outcomes, such as mortality and rebleeding rates, did not show significant differences 
between the two groups after propensity score matching in the two studies5,7. Although randomized controlled 
Figure 4. Forrest plot of rebleeding for comparison between the urgent and non-urgent groups.
Authors Patients (n) Death (n) Rebleeding (n)
Successful 
haemostasis (n)
Need for salvage 
therapy* (n) LOS (mean), days
Number of blood 
transfusions (mean), 
units per patient













Hsu et al. urgent: 176non-urgent: 135
urgent: 7
non-urgent: 18 NA 254** 57** NA NA




non-urgent: 25 NA NA NA NA




non-urgent: 25 NA NA
urgent: 4.0***
non-urgent: 4.0*** NA













Table 2. Overall mortality, rebleeding, successful haemostasis, need for salvage therapy, length of hospital stay, 
and number of units transfused in the five studies included. LOS, length of hospital stay; NA, not available. 
*This outcome included balloon tamponade, additional endoscopic therapy, or transjugular intrahepatic 
portosystemic shunt. **Only the total events were available. ***Data expressed as median values.
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trials are recognized as the best way for overcoming this limitation, it would be difficult because of obvious ethical 
issues. Second, significant heterogeneity was observed in the analyses of the main outcomes. Heterogeneity was 
also detected in the sensitivity analyses. These data suggest that factors other than those taken into account in 
these analyses might have affected the outcomes. Third, some data, including rebleeding rate, other outcomes, 
and factors that could affect treatment outcomes including vasoactive agents and antibiotics, were unavailable in 
some studies, thus, weakening the interpretation of our results. Finally, we could not evaluate the publication bias 
because of the small number of studies included. As a rule of thumb, tests for publication bias should be used only 
when there are at least 10 studies included in the meta-analysis19.
However, this study has some strengths. This is the first meta-analysis to report the optimal timing of endos-
copy in AVB. To date, current guidelines just recommend urgent endoscopy in AVB treatments. However, strong 
evidence is lacking except for some retrospective data about endoscopy timing. According to this study, to obtain 
favourable outcomes in the treatment of AVB, various factors (the patient’s condition, the feasibility of endos-
copy, and the expertise of endoscopists) related to the treatment outcomes must be considered. Moreover, proper 
medical treatment, such as the use of vasoactive agents, prophylactic antibiotics, and fluid resuscitation, may be 
more important than the timing of endoscopy. If the medical condition allows, endoscopic haemostasis in AVB 
should not be delayed. Thus, the development of current recommendation for the appropriate endoscopy timing 
in patients with AVB requires further large-scale studies.
In conclusion, this meta-analysis found that endoscopy timing did not affect the mortality or rebleeding rate 
in patients with AVB. Although our results require careful interpretation because of the heterogeneity between 
the studies included, endoscopic therapy should be performed at an appropriate timing depending on each 
patient’s condition.
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